Pharma & Life Sciences. Haloglide

Industry

Pharma & Life Sciences

Patient-safe traceability from manufacture to dispense. without bespoke integrations for every partner.

Why Haloglide

Built for pharma & life sciences.

When the product is a medicine, a vaccine or an implantable device, traceability stops being a compliance line item and becomes a patient-safety one. Diversion, falsification and slow recall execution all carry real human cost.

Haloglide gives manufacturers, distributors, hospitals and pharmacies a single, standards-based source of truth. aligned with GS1, EPCIS 2.0, DSCSA, EU FMD and the equivalent frameworks emerging worldwide. No proprietary lock-in. No silent black boxes.

Industry challenges

What gets in the way today.

Diversion and counterfeits

Grey-market and falsified medicines erode trust. and put patients at direct risk.

Recalls across many hands

Identifying every affected lot across distributors, hospitals and pharmacies is slow, manual and error-prone.

Partners on different formats

Trading partners run different systems and dialects. EPCIS exchange becomes painful and bespoke.

How Haloglide helps

Capabilities tuned for your sector.

Serial identity to the saleable unit

Every pack carries a unique identity in the global standard your trading partners and regulators already read, so a query resolves to specific units rather than a batch range.

A custody record that cannot be rewritten

Manufacture, distribution, dispense and return events are appended and timestamped. When an inspector asks where a unit has been, the answer is retrieved, not reconstructed.

Partner exchange without a new project

Distributors, hospitals and pharmacies exchange events in the standard format, so onboarding a new partner is configuration rather than another integration build.

Holds and exceptions in real time

Quarantines, temperature excursions and custody gaps appear as they happen, with the affected units already identified for your quality team.

Tampering shows itself

Because every event is signed, an inserted or altered record fails on sight instead of surviving until an annual review.

Written for the frameworks you answer to

Aligned with the United States drug supply chain security rules, the European falsified medicines framework and the equivalent regimes emerging elsewhere.

Outcomes

What changes for your team.

Patient safety, executed precisely

Withdraw the affected units and leave the rest of the supply in place.

Inspection without the scramble

Evidence is already in the format inspectors expect, on the day they ask.

Lower cost to stay compliant

Standard based exchange replaces the bespoke connection you currently build for every partner.

A day in the cockpit

Answer a withdrawal question in minutes, not days.

A temperature excursion is reported at a distribution centre. Quality opens the affected shipment, sees exactly which packs were involved, where each one is now, which have already been dispensed, and places a hold on the rest before the next delivery run leaves.

Quality and regulatory affairs

Custody history for any pack is retrieved rather than reconstructed, in the shape an inspector expects to read it.

Supply chain and distribution

Quarantines, excursions and custody gaps appear as they happen, with the affected units already identified.

Trading partner teams

Distributors, hospitals and pharmacies exchange events in the standard format, so a new partner is configuration rather than another integration build.

The platform behind patient safety

What your quality, supply and partner teams actually use.

The same platform, described the way a regulated medicines chain uses it: serialise the pack, hold the custody record intact, see the holds as they happen, and share only what each partner is entitled to see.